Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 5

Structural analysis of the choroid and the optic nerve in diabetes mellitus

Pages
1409–1414
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, inferior RNFL damage was correlated with higher HbA1clevels, showing that optic nerve changes differ by diabetic control.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to determine the choroidal and peri-optic nerve head retinal nerve fiber layer (RNFL) changes indiabetes mellitus (DM) patients without retinopathy.Material and Methods: Four groups of 70 eyes were defined: control group (healthy subjects); group 1 - DM patients with glycatedhemoglobin (HbA1c) level of 6.5–7.9%; group 2 (DM patients, HbA1c 8–9.5%); and group 3 (DM patients, HbA1c > 9.5%).
📊
Key Findings & Data:Opticalcoherence tomography measurements of choroidal thickness (CT) and RNFL changes and were compared within groups.Results: CT was thinner in diabetic groups compared with control, but this decrease was not directly proportional to the HbA1cincrease.
💡
Conclusion & Impact:However, inferior RNFL damage was correlated with higher HbA1clevels, showing that optic nerve changes differ by diabetic control.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to determine the choroidal and peri-optic nerve head retinal nerve fiber layer (RNFL) changes indiabetes mellitus (DM) patients without retinopathy.Material and Methods: Four groups of 70 eyes were defined: control group (healthy subjects); group 1 - DM patients with glycatedhemoglobin (HbA1c) level of 6.5–7.9%; group 2 (DM patients, HbA1c 8–9.5%); and group 3 (DM patients, HbA1c > 9.5%). Opticalcoherence tomography measurements of choroidal thickness (CT) and RNFL changes and were compared within groups.Results: CT was thinner in diabetic groups compared with control, but this decrease was not directly proportional to the HbA1cincrease. CT loss in the subfovea was only seen in group 1. In temporal quadrant, all diabetic groups had RNFL loss compared withcontrol, with no difference between them. RNFL in groups 2 and 3 had significant loss in the inferior temporal area compared withthe control group, whereas in the inferior nasal quadrant, only group 3 had significant loss.Conclusion: CT changes were consistently seen in the lower HbA1c group compared with healthy subjects. This could be the resultof the combined effect of low blood flow - which leads to CT decrease- that is then rivaled by the choroidal thickening due toincreased vessel rigidity that is observed because of diabetic inflammation and high glycation end-product accumulation. RNFL wasaffected in temporal quadrants regardless to glycemic control. However, inferior RNFL damage was correlated with higher HbA1clevels, showing that optic nerve changes differ by diabetic control.

🔖

Cite This Article

ERCAN, Z. E. (2022). Structural analysis of the choroid and the optic nerve in diabetes mellitus. Annals of Medical Research, Cilt: 27 - Sayı: 5, 1409–1414. https://ajindex.com/articles/446475

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Shiba C, Shiba T, Takahashi M, et al.Relationship between glycosylated hemoglobin A1c and ocular circulation by laser speckle flowgraphy in patients with/without diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2016;254:1801-9
  2. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7
  3. Shiragami C, Shiraga F, Matsuo T, et al. Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2002;240:436-42
  4. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91
  5. Joanna K, Lucia M, Piotr W, et al.Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss. Current Neuropharmacology 2016;14:831-9
  6. Chihara E, Matsuoka T, Ogura Y, et al. Retinal Nerve Fiber Layer Defect as an Early Manifestation of Diabetic Retinopathy. Ophthalmology 1993;100:1147- 51
  7. Picconi F, Parravano M, Ylli D, et al. Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta Diabetologica 2017;54:489-97
  8. Shi R, Guo Z, Wang F, et al. Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors. Current Eye Research 2018;43:244-53
  9. Masuch A, Friedrich N, Roth J, et al. Preventing misdiagnosis of diabetes in the elderly: agedependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocrine Disorders 2019;19:20
  10. Bressler SB, Odia I, Maguire MG, et al. Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial. JAMA Ophthalmol 2019
  11. Thompson IA, Durrani AK, Patel S. Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy. Eye (Lond) 2018
  12. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science (New York, NY). 1991;254:1178- 81
  13. Wu H, de Boer JF, Chen TC. Reproducibility of retinal nerve fiber layer thickness measurements using spectral domain optical coherence tomography. J Glaucoma 2011;20:470-12
  14. Abadia B, Sunen I, Calvo